The Effectiveness of Psychological Interventions for Common Mental Disorders

NCT ID: NCT06916429

Last Updated: 2025-10-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

308 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-01

Study Completion Date

2027-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim of "the Effectiveness of Psychological Interventions for Common mental disorders" (EPIC) randomized controlled trial is to investigate whether a significantly larger symptom improvement is observed after approximately four months of psychotherapeutic treatment in the Danish primary sector compared to in a waiting list control group. The secondary aim of the study is to identify specific client and therapy characteristics that may predict the effectiveness of the therapy or the symptom development in the waiting list control group. The main hypothesis of the EPIC trial is:

1\) Four and a half months after randomization, we will find a significantly lower level of symptoms on the primary outcome measure (PHQ-ADS) among clients who receive psychotherapy, compared to clients in the waiting list control group. In addition, we hypothesize to find significantly better outcomes in the psychotherapy group on all secondary outcome measures, four and a half months after randomization.

Researchers will compare:

* Psychotherapy starting within 14 days after the randomization date with
* Placement on a waiting list for psychotherapy with treatment starting approximately four and a half months after the randomization date

to investigate whether a larger symptom improvement is observed in the group receiving psychotherapy compared to the waiting list control group.

Participants will:

* Be referred by their general practitioner (GP) for publicly subsidized psychotherapy treatment in the primary care sector in Denmark, based on one of 11 referral reasons.
* Complete the baseline questionnaire containing background information, the primary and secondary outcome measures, and predictor questionnaires, and subsequently be randomized to either psychotherapy beginning within two weeks or a waiting list control group.
* Receive a brief symptom questionnaire (the PHQ-ADS) every other week after the randomization date via an SMS-based solution provided by REDCap.
* Complete the primary and secondary outcome measures approximately four and a half, eight and a half, and 16 and a half months after the randomization date.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aims:

The primary aim of this randomized controlled trial is to investigate whether a significantly higher symptom improvement is observed after approximately four months of psychotherapeutic treatment in the Danish primary sector compared to a waiting list control group. A supplementary aim is to explore whether the treatment effect is maintained during follow-up assessed approximately eight and 16 months after the beginning of treatment. The secondary aim of the study is to investigate whether specific client and therapy characteristics predicting the effect of the therapy and the symptom change in the waitlist control group can be identified, and whether the quality of the therapeutic alliance measured after approximately five weeks of therapy is related to the outcome of therapy.

The hypotheses of the study are as follows:

1. Four and a half months after randomization, we will find a significantly lower level of symptoms on the primary outcome measure (PHQ-ADS) among clients who receive psychotherapy, compared to clients in the waiting list control group. In addition, we hypothesize to find significantly better outcomes in the psychotherapy group on all secondary outcome measures, four and a half months after randomization.
2. We expect that the client's coping strategies, emotion regulation strategies, and level of personality pathology will be significantly related to symptom change and treatment dropout amongst the clients receiving psychotherapy, and to symptom change in the waitlist group, four and a half months after randomization.
3. We expect that the quality of the working alliance after approximately five weeks of therapy will be significantly related to symptom change on the PHQ-ADS after four and a half months of therapy. Conversely, we do not expect that the therapeutic orientation of the psychologist will be independently related to symptom change after four and a half months of therapy.
4. We will explore whether the symptom change observed after approximately four and a half months persists eight and a half and 16 and a half months after the beginning of therapy.

Primary Analysis:

\- The primary analysis of the general treatment effect in the practice sector will consist of a multilevel longitudinal regression model. This model will assess the difference in the rate of change between the intervention group and the control group in the PHQ-ADS scores over a period of approximately four months of therapy.

Secondary Analyses:
* As a secondary analysis of the treatment effect, a multilevel logistic regression model will compare the difference in reliable remission rates on the PHQ-9 and the GAD-7 between the intervention group and the control group after approximately four months of therapy. The reliable remission rates on the PHQ-9 and the GAD-7 are employed by the IAPT in the UK and the PMHC in Norway, enabling us to benchmark our results with other studies examining the impact of psychotherapy in primary sectors similar to Denmark.
* Another secondary analysis of the treatment effect will compare differences between the intervention group and the control group after approximately four months of therapy on the secondary continuous outcome measures, specifically the SPS, the CPS, the WHO-5, and the NEQ (see Measures).
* Finally, in a secondary analysis of the treatment effect at follow-up, multilevel regression models will compare the pre-post change in the treatment group approximately eight and 16 months after the beginning of therapy with the change found after four months, and multilevel logistic regression models will compare the reliable remission rates on the PHQ-9 and the GAD-7 found at eight and 16 months with the rate found after approximately four months.

Secondary Predictor Analyses:
* In addition, we will conduct multilevel longitudinal regression models using the predictor variables (i.e., the client's sociodemographic and clinical characteristics, coping strategies, emotion regulation strategies, and level of personality pathology) as fixed effect predictors. The dependent variable will be the rate of change in the PHQ-ADS, measured in both arms of the trial after approximately four months of therapy. Moreover, we will conduct multilevel logistic regression analyses and repeat the predictor analyses in both arms of the study, using the treatment dropout rate as a binary dependent variable.
* Moreover, a multilevel regression model on the association between the client-rated working alliance after approximately five weeks of therapy and the rate of change in the PHQ-ADS after approximately four months of therapy is conducted. In this analysis, the change score on the PHQ-ADS from treatment start to the fifth therapy week will be included as a covariate.

All analyses are conducted as intention-to-treat with multiple imputations of missing data.

Study Design:

The study is designed as a pragmatic randomized controlled trial with a block randomization of clients referred by their general practitioner (GP) for psychotherapy treatment in the primary care sector in Denmark. The clients are randomized in a 1:1 allocation ratio to one of the following options:
* Psychotherapy starting within 14 days of the randomization date
* Placement on a waiting list for psychotherapy, with treatment starting four and a half months after the randomization date.

Participants:

Participants will typically be referred by their GP based on one of 11 referral reasons, which include:
* Victims of traffic and other accidents
* Relatives of seriously mentally ill persons
* Persons suffering from a seriously debilitating illness
* Relatives of persons suffering from a seriously debilitating illness
* Relatives of recently deceased persons
* Persons who have attempted suicide
* Women having undergone an induced abortion after the 12th week of pregnancy
* Persons who, before the age of 18, have been victims of incest or other sexual assaults
* Persons aged 18 or above with mild to moderate depression
* Persons aged 18 or above with mild to moderate anxiety disorder, including mild to moderate OCD.

Procedure:
* Psychologists practicing in the Danish primary sector who have a waiting time of at least four months for psychotherapy treatment will be recruited for the study.
* The participating psychologists will inform all new clients referred by a GP about the possibility of participating in the trial.
* Clients who provide written consent will automatically receive the first set of questionnaires.
* Clients who complete the baseline questionnaires are subsequently randomized to either psychotherapy beginning within two weeks or a waiting list.
* Clients in either arm of the trial will receive the PHQ-ADS (see Outcome Measures) every other week via an SMS-based solution provided by REDCap.
* All questionnaires mentioned under the section on "primary and secondary outcome measures" in the section on Outcome Measures are sent out approximately four and a half, eight and a half, and 16 and a half months after the date of the randomization.

Ethics:
* The study has been approved by the Institutional Review Board at the Department of Psychology, University of Copenhagen.
* All data will be stored on drives approved by the Danish Data Protection Authority as appropriately secure, and all rules from the General Data Protection Regulation will be respected.

Dissemination of Results:
* The results of the study will be disseminated in at least two scientific articles published in international peer-reviewed journals.
* In addition, a report will be prepared for the Danish Regions and the Danish Psychological Association, presenting the conclusions of the study and its possible implications for practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Common Mental Disorders and/or Stress Related Symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Wailist Control Group

Description: Clients in the waitlist control group will be placed on a waiting list for psychotherapy with treatment starting approximately four and a half months after the date of randomization.

Objective: To serve as a control group to the intervention group receiving psychotherapy and to investigate distinct symptom trajectories during the waiting period.

Group Type OTHER

Waiting List for Psychotherapeutic Treatment

Intervention Type OTHER

Treatment: During the waiting list period, clients will not receive any psychotherapeutic treatment for their mental health issues in the Danish primary sector. However, their general practitioner may refer them to appropriate psychiatric treatment if their mental condition worsens and requires immediate treatment.

Procedure: Clients in the waiting list group will fill in questionnaires on their symptom development during the waiting period. They will complete the same set of predictor and outcome questionnaires as the psychotherapy group.

Psychotherapy Intervention Group

Description: Clients in the psychotherapy intervention group will receive psychotherapeutic treatment with treatment starting within 14 days of the randomization date.

Objective: To determine the effectiveness of psychotherapy in the Danish primary sector over approximately a four-month period.

Group Type EXPERIMENTAL

Psychotherapeutic treatment

Intervention Type OTHER

The psychotherapeutic treatment will reflect the therapy practices that characterize the Danish primary sector.

Treatment: Clients are referred by their GP to receive up to 12 individual psychotherapy sessions, typically of 50-60 minutes' duration. For clients with depression and anxiety as referral reason, it is possible to get a supplementary referral by the GP ensuring 12 more sessions, totaling 24 sessions of therapy.

Procedure: Due to the Danish primary sector having relative freedom in method of choice, the psychologist carries out the psychotherapy according to the treatment principles they consider the most relevant, without clauses regarding specific models of therapy or manualization. The therapists register the therapeutic approaches and interventions used in each course of therapy on The Multitheoretical List of Therapeutic Interventions (MULTI-30)at the end of each treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Psychotherapeutic treatment

The psychotherapeutic treatment will reflect the therapy practices that characterize the Danish primary sector.

Treatment: Clients are referred by their GP to receive up to 12 individual psychotherapy sessions, typically of 50-60 minutes' duration. For clients with depression and anxiety as referral reason, it is possible to get a supplementary referral by the GP ensuring 12 more sessions, totaling 24 sessions of therapy.

Procedure: Due to the Danish primary sector having relative freedom in method of choice, the psychologist carries out the psychotherapy according to the treatment principles they consider the most relevant, without clauses regarding specific models of therapy or manualization. The therapists register the therapeutic approaches and interventions used in each course of therapy on The Multitheoretical List of Therapeutic Interventions (MULTI-30)at the end of each treatment.

Intervention Type OTHER

Waiting List for Psychotherapeutic Treatment

Treatment: During the waiting list period, clients will not receive any psychotherapeutic treatment for their mental health issues in the Danish primary sector. However, their general practitioner may refer them to appropriate psychiatric treatment if their mental condition worsens and requires immediate treatment.

Procedure: Clients in the waiting list group will fill in questionnaires on their symptom development during the waiting period. They will complete the same set of predictor and outcome questionnaires as the psychotherapy group.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

psychological treatment psychotherapy psychological intervention waitlist waiting list control group waitlist for therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Clients:

* All clients who meet the criteria for one of the eleven referral reasons for psychotherapeutic treatment in the Danish primary sector.
* Clients who read and speak proficient Danish to fill in the questionnaires.
* Clients who agree to be randomized through their informed consent.

Psychologists:

* All practicing psychologists employed by the Danish primary sector.
* Psychologists who can commit to the deadlines for beginning treatment.
* Psychologists with at waiting time of approximately four months or longer.

Exclusion Criteria

\- Clients considered unfit for participation or urgently needing psychological or medical help, as determined by the therapist.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

the Danish Psychological Association

UNKNOWN

Sponsor Role collaborator

The Danish Regions: Foundation for Medical Research

UNKNOWN

Sponsor Role collaborator

University of Copenhagen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stig Poulsen, Professor

Role: PRINCIPAL_INVESTIGATOR

University of Copenhagen

Ole Karkov Østergård, Associate Professor

Role: STUDY_CHAIR

Aalborg University

Carsten Hjorthøj, Associate Professor

Role: STUDY_CHAIR

University of Copenhagen

Celia Faye Jacobsen, PhD

Role: STUDY_CHAIR

University of Copenhagen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Copenhagen

Copenhagen, Central Region, Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Celia Faye Jacobsen, PhD

Role: CONTACT

45+ 22261168

Stig Poulsen, Professor

Role: CONTACT

45 + 28593543

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Celia Faye Jacobsen, PhD

Role: primary

45 + 22261168

Stig Poulsen, Professor

Role: backup

45 + 28593543

Related Links

Access external resources that provide additional context or updates about the study.

https://psy.ku.dk/epic/

The official website for the EPIC trial

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IP-EC-19012024-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.